Scholarlink

Objective <p>Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) and endovascular therapy (EVT) are established treatments for acute ischemic stroke (AIS) due to large vessel occlusion (LVO) in the anterior circulation. This study aimed to compare the safety and efficacy of bridging therapy (rt-PA before EVT) versus direct EVT in a real-world, multicenter setting.</p> Methods <p>In this retrospective multicenter cohort study, 724 patients with anterior circulation AIS treated with EVT within 8&#xa0;h of symptom onset were analyzed. Patients received either pre-EVT rt-PA (n = 314) or direct EVT without rt-PA (n = 410). Primary outcomes included 3-month functional independence (modified Rankin Scale (mRS) 0–2), excellent outcome (mRS 0–1), and mortality. Secondary outcomes included hemorrhagic transformation, parenchymal hematoma, and successful reperfusion (mTICI ≥ 2b). Multivariate logistic regression was adjusted for key clinical confounders.</p> Results <p>Baseline characteristics were comparable, except for higher median NIHSS scores in the direct EVT group (16 vs. 15, p &lt; 0.001). No significant differences were observed in 3-month functional independence (43.0% vs. 50.3%, p = 0.051), excellent outcome (36.8% vs. 42.0%, p = 0.155), or mortality (22.9% vs. 20.1%, p = 0.354). Hemorrhagic transformation and parenchymal hematoma rates were similar. Although successful reperfusion was higher in the rt-PA group (93.6% vs. 88.5%, p = 0.019), this did not remain significant after adjustment.</p> Conclusion <p>Pre-EVT rt-PA did not improve functional outcomes or reduce mortality in AIS patients. While rt-PA showed a trend toward higher reperfusion rates, this did not translate to clinical benefit. Hemorrhage risks were similar between groups.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Direct thrombectomy versus bridging alteplase medicine in anterior circulation stroke following endovascular therapy: a multi-center cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月4日

查看全文
  • Xuehua Zeng,
  • Mingzhu Feng,
  • Mohammad Mofatteh,
  • Lue Chen,
  • Jian Yi,
  • Zunbao Xu,
  • Zile Yan,
  • Jicai Ma,
  • Sijie Zhou,
  • Haiping Wang,
  • Xiaofeng Lin,
  • Yuzheng Lai,
  • Wenhong Peng,
  • Minhua Zhou,
  • Shuiquan Yang

摘要

Objective

Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) and endovascular therapy (EVT) are established treatments for acute ischemic stroke (AIS) due to large vessel occlusion (LVO) in the anterior circulation. This study aimed to compare the safety and efficacy of bridging therapy (rt-PA before EVT) versus direct EVT in a real-world, multicenter setting.

Methods

In this retrospective multicenter cohort study, 724 patients with anterior circulation AIS treated with EVT within 8 h of symptom onset were analyzed. Patients received either pre-EVT rt-PA (n = 314) or direct EVT without rt-PA (n = 410). Primary outcomes included 3-month functional independence (modified Rankin Scale (mRS) 0–2), excellent outcome (mRS 0–1), and mortality. Secondary outcomes included hemorrhagic transformation, parenchymal hematoma, and successful reperfusion (mTICI ≥ 2b). Multivariate logistic regression was adjusted for key clinical confounders.

Results

Baseline characteristics were comparable, except for higher median NIHSS scores in the direct EVT group (16 vs. 15, p < 0.001). No significant differences were observed in 3-month functional independence (43.0% vs. 50.3%, p = 0.051), excellent outcome (36.8% vs. 42.0%, p = 0.155), or mortality (22.9% vs. 20.1%, p = 0.354). Hemorrhagic transformation and parenchymal hematoma rates were similar. Although successful reperfusion was higher in the rt-PA group (93.6% vs. 88.5%, p = 0.019), this did not remain significant after adjustment.

Conclusion

Pre-EVT rt-PA did not improve functional outcomes or reduce mortality in AIS patients. While rt-PA showed a trend toward higher reperfusion rates, this did not translate to clinical benefit. Hemorrhage risks were similar between groups.